Total Payments
$1.1M
2024 Payments
$444,054
Companies
43
Transactions
1,433
Medicare Patients
3,776
Medicare Billing
$874,253
Payment Breakdown by Category
Other$674,638 (62.9%)
Consulting$276,094 (25.7%)
Travel$79,692 (7.4%)
Food & Beverage$37,766 (3.5%)
Education$5,151 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $656,211 | 206 | 61.1% |
| Consulting Fee | $276,094 | 73 | 25.7% |
| Travel and Lodging | $79,692 | 221 | 7.4% |
| Food and Beverage | $37,766 | 915 | 3.5% |
| Honoraria | $13,527 | 7 | 1.3% |
| Education | $5,151 | 10 | 0.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,900 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $136,595 | 139 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $136,189 | 92 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $129,596 | 159 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $120,644 | 66 | $0 (2024) |
| Janssen Biotech, Inc. | $116,113 | 173 | $0 (2024) |
| Galderma Laboratories, L.P. | $92,491 | 103 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $86,112 | 66 | $0 (2024) |
| Incyte Corporation | $49,839 | 58 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $43,541 | 93 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $33,613 | 86 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $444,054 | 425 | Regeneron Healthcare Solutions, Inc. ($114,948) |
| 2023 | $395,778 | 486 | PFIZER INC. ($74,042) |
| 2022 | $131,623 | 154 | Sun Pharmaceutical Industries Inc. ($31,905) |
| 2021 | $53,842 | 139 | Novartis Pharmaceuticals Corporation ($15,063) |
| 2020 | $18,487 | 48 | Sun Pharmaceutical Industries Inc. ($7,349) |
| 2019 | $22,973 | 98 | Ortho Dermatologics, a division of Bausch Health US, LLC ($12,001) |
| 2018 | $4,094 | 50 | Ortho Dermatologics, a division of Bausch Health US, LLC ($1,975) |
| 2017 | $2,491 | 33 | Valeant Pharmaceuticals North America LLC ($566.57) |
All Payment Transactions
1,433 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Almirall LLC | Klisyri (Drug) | Honoraria | Cash or cash equivalent | $2,400.00 | General |
| Category: Dermatology | ||||||
| 12/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,440.00 | General |
| Category: Oncology | ||||||
| 12/19/2024 | Almirall LLC | Klisyri (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $3,712.50 | General |
| 12/17/2024 | Janssen Scientific Affairs, LLC | — | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| 12/17/2024 | Janssen Scientific Affairs, LLC | — | Travel and Lodging | Cash or cash equivalent | $8.04 | General |
| 12/16/2024 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,150.00 | General |
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,215.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,925.00 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | PFIZER INC. | CIBINQO (Drug) | Travel and Lodging | In-kind items and services | $1,083.34 | General |
| Category: Inflammation & Immunology | ||||||
| 12/13/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $38.66 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,840.00 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Almirall LLC | Klisyri (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Travel and Lodging | In-kind items and services | $663.83 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Travel and Lodging | In-kind items and services | $605.45 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $124.73 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,887.50 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,570.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | PFIZER INC. | CIBINQO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: Inflammation & Immunology | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $6,450.00 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,440.00 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $322.50 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 1,488 | 4,164 | $1.3M | $542,918 |
| 2022 | 6 | 116 | 277 | $59,945 | $20,600 |
| 2021 | 15 | 577 | 910 | $183,138 | $84,294 |
| 2020 | 23 | 1,595 | 2,724 | $449,521 | $226,441 |
Total Patients
3,776
Total Services
8,075
Medicare Billing
$874,253
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| Q4257 | Relese, per square centimeter | Office | 2023 | 13 | 238 | $343,196 | $134,533 | 39.2% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 25 | 552 | $264,309 | $115,134 | 43.6% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 25 | 486 | $154,875 | $67,802 | 43.8% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 89 | 125 | $148,192 | $59,084 | 39.9% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 25 | 533 | $38,740 | $16,859 | 43.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 193 | 193 | $32,387 | $14,912 | 46.0% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 37 | 46 | $33,534 | $14,783 | 44.1% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 24 | 82 | $27,893 | $12,286 | 44.0% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 20 | 25 | $28,579 | $10,760 | 37.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 135 | 163 | $26,590 | $10,525 | 39.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 47 | 51 | $42,389 | $9,659 | 22.8% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Office | 2023 | 69 | 118 | $21,091 | $9,435 | 44.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 83 | 88 | $15,482 | $7,069 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 94 | $14,485 | $6,572 | 45.4% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 23 | 26 | $18,940 | $6,167 | 32.6% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 22 | 81 | $12,492 | $5,351 | 42.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 134 | 154 | $16,071 | $5,207 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 53 | $12,364 | $5,142 | 41.6% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 18 | 19 | $13,493 | $4,697 | 34.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 57 | 104 | $8,173 | $4,077 | 49.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 27 | 29 | $7,706 | $3,750 | 48.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $7,786 | $3,199 | 41.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 110 | 645 | $6,845 | $3,178 | 46.4% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 26 | 52 | $6,094 | $2,670 | 43.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 20 | $8,861 | $2,014 | 22.7% |
About Dr. Aaron Farberg, M.D
Dr. Aaron Farberg, M.D is a MOHS-Micrographic Surgery healthcare provider based in Rockwall, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2012. The National Provider Identifier (NPI) number assigned to this provider is 1134480239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Farberg, M.D has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $444,054 received in 2024. These payments were reported across 1,433 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($656,211).
As a Medicare-enrolled provider, Farberg has provided services to 3,776 Medicare beneficiaries, totaling 8,075 services with total Medicare billing of $874,253. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location Rockwall, TX
- Active Since 06/05/2012
- Last Updated 06/20/2023
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1134480239
Products in Payments
- LIBTAYO (Biological) $135,589
- TREMFYA (Drug) $126,267
- CIBINQO (Drug) $107,606
- SPEVIGO (Drug) $89,962
- Sotyktu (Drug) $55,289
- ILUMYA (Biological) $54,357
- OPZELURA (Drug) $47,321
- Odomzo (Drug) $41,480
- AKLIEF (Drug) $38,492
- Winlevi (Drug) $25,781
- COSENTYX (Biological) $24,895
- SILIQ (Drug) $21,267
- SKYRIZI (Biological) $20,730
- DUPIXENT (Biological) $15,561
- Otezla (Drug) $11,307
- Klisyri (Drug) $10,938
- EUCRISA (Drug) $10,799
- COSENTYX (Drug) $9,273
- VTAMA (Drug) $9,119
- INFLECTRA (Biological) $7,993
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.